ஆராய்ச்சி இயக்குனர் பீட்டர் மதிப்பெண்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
FDA advisers to consider giving green light to Pfizer booster
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
The headwinds to making generics in the U S
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
By EMILY KOPP | CQ-Roll Call | Published: May 12, 2021
Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See more staff and wire stories here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription. (Tribune News Service) Senators on Tuesday pressed President Joe Biden s top health officials to address the slowing pace of COVID-19 vaccinations as an administration adviser raised the possibility that booster shots may be needed within the next year. Everyone must have the opportunity to get vaccinated regardless of race, zip code, disability, primary language, or internet access, said Senate Health, Education, Labor and Pensions Chair Patty Murray, D-Wash. We are also seeing the vaccination rate slow a reminder that making sure people can get vaccines is just half the battle. We need to make sure they do get them.
COVID-19: US children aged 12 to 15 could get jabs from tomorrow
Reuters
US regulators have authorized the Pfizer and BioNTech COVID-19 vaccine for use in children as young as 12 and said they could begin receiving shots as soon as tomorrow, widening the nation’s inoculation program as vaccination rates have slowed significantly.
It is the first COVID-19 vaccine to be authorized in the US for ages 12 to 15.
Vaccinating younger ages is considered an important step for getting children back into schools safely.
US President Joe Biden has asked states to make the vaccine available to younger adolescents immediately.
Biden issued a statement hailing the authorization as “a promising development in our fight against the virus.”
FDA and CDC field media questions regarding Johnson and Johnson vaccine pause
Leaders with the Centers for Disease Control and Prevention teamed up with those heading up the U.S. Food and Drug Administration today to field reporters from across the nation after issuing a joint recommendation for a pause in the use of the Johnson and Johnson vaccine out of an abundance of caution this morning.
Six in 6.8 million, the number of reported cases of people in the U.S. who developed dangerous blood clots after receiving the Johnson and Johnson COVID-19 vaccine, prompting the CDC and FDA to take swift action Tuesday out of an abundance of caution. Acting FDA Commissioner Janet Woodcock said, “This morning the FDA and CDC announced that out of an abundance of caution we’re recommending a pause of the Johnson & Johnson COVID-19 vaccine due to reports of six cases of a rare and severe type of blood clot following vaccine administration. We’re recommending this pause while we work toget
vimarsana © 2020. All Rights Reserved.